The prevalence of ER-low-positive breast cancer and its relation to tumor characteristics in Syria Cover

.blurhash-client-img { display: none !important; }

The prevalence of ER-low-positive breast cancer and its relation to tumor characteristics in Syria

Forum of Clinical Oncology

Volume 14 (2023): Issue 3 (December 2023)

By: Remal Abdulaziz Asaad, Hla Sudan, Bailasan Hasan and Siraj Saadaldin Abdullah

Open Access

|Sep 2024

Authors

Remal Abdulaziz Asaad

rimalasaad@tishreen.edu.sy

Clinical Biochemistry, Department of Biochemistry and Microbiology, Faculty of Pharmacy, Tishreen University, Latakia, Syria

Hla Sudan

Master in Laboratory Diagnosis, Department of Biochemistry and Microbiology, Faculty of Pharmacy, Tishreen University, Latakia, Syria

Bailasan Hasan

Master in Laboratory Diagnosis, Department of Biochemistry and Microbiology, Faculty of Pharmacy, Tishreen University, Latakia, Syria

Siraj Saadaldin Abdullah

Department of Surgery, National Hospital of Jableh, Latakia, Syria

DOI: https://doi.org/10.2478/fco-2023-0028 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 56 - 62

Submitted on: Jan 20, 2024

Accepted on: May 21, 2024

Published on: Sep 28, 2024

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

ER-low-positive breast cancer,

lymph node ratio—LNR,

invasive ductal carcinoma—IDC

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2024 Remal Abdulaziz Asaad, Hla Sudan, Bailasan Hasan, Siraj Saadaldin Abdullah, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 14 (2023): Issue 3 (December 2023)Next article